|
|
Article: NASONEX(R) Now FDA-Approved in United States for Nasal Polyps.
- Article from:
- PR Newswire Europe
- Article date:
- December 16, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
KENILWORTH, New Jersey, December 16 /PRNewswire/ --
- First and only nasal inhaled steroid in U.S. for treatment of this condition
Schering-Plough Corporation (NYSE: SGP) today announced that the U.S. Food and Drug Administration (FDA) has approved NASONEX(R) (mometasone furoate monohydrate) Nasal Spray, 50 mcg(-) for the treatment of nasal polyps in patients 18 years of age and older.(1) This marks the first and only FDA-approval of a nasal inhaled steroid for the treatment of this condition prior to surgery. Nasal polyps are grape-like growths in the nasal cavity that reduce airflow in the nasal passages, leading to congestion.
"The approval ...